Latest Articles

Publication Date
All News Scientific
Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position - TipRanks

Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position TipRanks

Published: April 1, 2025, 6:54 p.m.
Read Full Article
Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results The Manila Times

Published: March 27, 2025, 10:06 p.m.
Read Full Article
Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results GlobeNewswire

Published: March 27, 2025, 9:46 p.m.
Read Full Article
Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results - TradingView

Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results TradingView

Published: March 27, 2025, 9:44 p.m.
Read Full Article
Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer - Business Wire

Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer Business Wire

Published: March 12, 2025, 5:34 p.m.
Read Full Article
Lisata Therapeutics Inc (LSTA) Q4 2024 Earnings Call Highlights: Promising Developments Amid ... - Yahoo Finance

Lisata Therapeutics Inc (LSTA) Q4 2024 Earnings Call Highlights: Promising Developments Amid ... Yahoo Finance

Published: Feb. 28, 2025, 7:35 a.m.
Read Full Article
Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - Yahoo Finance

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update Yahoo Finance

Published: Feb. 27, 2025, 9:05 p.m.
Read Full Article
Real world perspectives on endometriosis disease phenotyping through surgery, omics, health data, and artificial intelligence.

Endometriosis is an enigmatic disease whose diagnosis and management are being transformed through innovative surgical, molecular, and computational technologies. Integrating single-cell and other omic disease data with clinical and surgical …

Published: Feb. 6, 2025, midnight
Read Full Article
Diseases Physiology Reproductive disorders
Acrivon Therapeutics Announces FDA has Granted Breakthrough - GlobeNewswire

Acrivon Therapeutics Announces FDA has Granted Breakthrough GlobeNewswire

Published: Feb. 5, 2025, 1:19 p.m.
Read Full Article
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer - The Manila Times

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer The Manila Times

Published: Feb. 5, 2025, 1:07 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!